Vérification…
Traduit automatiquement. Doses et mises en garde : vérifiez l'original en anglais. Lire en anglais

Vifazer Syrup

NAFDAC REG NO: B4-5595 Médicament

Enregistré auprès de NAFDAC. Enregistrement actifAs of 1 November 2026 · synced automatically from official sources.
Produit
Vifazer Syrup
Numéro NAFDAC
B4-5595
Principe actif
Salbutamol (Salbutamol Sulfate); Bromhexine (Bromhexine Hydrochloride); Guaifenesin
Dosage
1 mg/5 mL; 2 mg/5 mL; 50 mg/5 mL
Forme
Syrup
Conditionnement
1 x 100 mL (in PET bottle)
Fabricant
Non répertorié
Déposant / Titulaire :
Emcure Nigeria Limited
Approuvé
6 Jul 2023
Statut
Actif Vue sur NAFDAC ↗
Enregistrement valable jusqu'au
5 Jul 2028
Alertes OMS
Non trouvé
Community reports
None
Times checked
0

About the medicine: Salbutamol: uses, dosage and brands worldwide

What we found

  • Vifazer Syrup is on the NAFDAC register with an active registration (B4-5595). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Vifazer Syrup

Ce que dit la notice officielle. Si un médecin vous l'a prescrit, suivez l'ordonnance. La notice de votre boîte prime si elle est différente.

Pour qui

Albuterol tablets, USP are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease.

Comment le prendre et à quelle fréquence
  • The following dosages of albuterol tablets, USP are expressed in terms of albuterol base
  • Usual Dosage
  • Pediatric Patients 6 to 12 Years of Age: For pediatric patients 6 to 12 years of age, the usual dosage is 2 mg three or four times a day
  • Adults and Pediatric Patients Over 12 Years of Age: For adults and pediatric patients over 12 years of age, the usual starting dosage is 2 or 4 mg three or four times a day
  • Dosage Adjustment
  • Pediatric Patients 6 to 12 Years of Age Who Fail to Respond to the Initial Starting Dosage of 2 mg Four Times a Day : For pediatric patients from 6 to 12 years of age who fail to respond to the initial starting dosage of 2 mg four times a day, the dosage may be cautiously increased stepwise, but not to exceed 24 mg/day (given in divided doses)
  • Adults and Pediatric Patients Over 12 Years of Age: For adults and pediatric patients over 12 years of age, a dosage above 4 mg four times a day should be used only when the patient fails to respond to lower dose
  • The dosage should be cautiously increased stepwise up to a maximum of 8 mg four times a day as tolerated if a favorable response does not occur with the 4 mg initial dosage
  • Elderly Patients and Those Sensitive to Beta-adrenergic Stimulators : An initial dosage of 2 mg three or four times a day is recommended for elderly patients and for those with a history of unusual sensitivity to beta-adrenergic stimulators
  • If adequate bronchodilation is not obtained, dosage may be increased gradually as tolerated to as much as 8 mg three or four times a day. …
Talk to a doctor first if

Albuterol tablets are contraindicated in patients with a history of hypersensitivity to albuterol, or any of their components.

Medicines it may not mix with

The concomitant use of albuterol tablets and other oral sympathomimetic agents is not recommended since such combined use may lead to deleterious cardiovascular effects. This recommendation does not preclude the judicious use of an aerosol bronchodilator of the adrenergic stimulant type in patients receiving albuterol tablets. Such concomitant use, however, should be individualized and not given on a routine basis. If regular co-administration is required, then alternative therapy should be considered. …

Warnings

Paradoxical Bronchospasm Albuterol tablets can produce paradoxical bronchospasm, which may be life threatening. If paradoxical bronchospasm occurs, albuterol tablets should be discontinued immediately and alternative therapy instituted. Deterioration of Asthma Asthma may deteriorate acutely over a period of hours, or chronically over several days or longer. If the patient needs more doses of albuterol tablets than usual, this may be a marker of destabilization of asthma and requires re-evaluation of the patient and the treatment regimen, giving special consideration to the possible need for anti-inflammatory treatment, e.g., corticosteroids. …

Effets secondaires possibles

The adverse reactions to albuterol are similar in nature to those of other sympathomimetic agents. Albuterol Tablets Adverse Experience Incidence (% of patients) in Adults and Children 6 Years of Age and Older Adverse Event Percent Incidence Central nervous system Nervousness 20 Tremor 20 Headache 7 Dizziness 2 Weakness 2 Sleeplessness 2 Irritability < 1 Drowsiness < 1 Restlessness < 1 Cardiovascular Palpitations 5 Tachycardia 5 Flushing < 1 Chest discomfort < 1 Musculoskeletal Muscle cramps 3 Gastrointestinal Nausea 2 Genitourinary Difficulty in micturition < 1 Albuterol Extended-release Tablets Incidence of Adverse Reactions (% of Patients) in a 1-week Clinical Trials* Adverse Event Albute …

If you take too much

The expected symptoms with overdosage are those of excessive beta-adrenergic stimulation and/or occurrence or exaggeration of any of the symptoms listed under ADVERSE REACTIONS , e.g., angina, hypertension tachycardia with rates up to 200 beats per minute, nervousness, headache, tremor, dry mouth, palpitation, nausea, dizziness, and insomnia. In addition, seizures, hypotension, arrhythmias, fatigue, malaise and hypokalemia may also occur. As with all sympathomimetic medications, cardiac arrest and even death may be associated with abuse of albuterol tablets. …

En cas d'oubli

Prenez-le dès que vous y pensez, sauf s'il est presque l'heure de la dose suivante. Dans ce cas, sautez la dose oubliée. Ne prenez jamais deux doses à la fois pour compenser. Vérifiez votre notice, certains médicaments font exception.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2026-04-14.

Label for salbutamol (salbutamol sulfate) and bromhexine (bromhexine hydrochloride) and guaifenesin, the active ingredient registered with NAFDAC.

Check your pack of Vifazer Syrup

Add the expiry date on your pack for a full Trust Score.

Ou prenez la boîte en photo
Encore 3 vérifications gratuites aujourd'hui Sources officielles : FDA américaine · EMA (UE) · NAFDAC · alertes OMS

About Vifazer Syrup

What is in Vifazer Syrup?

Vifazer Syrup contains Salbutamol (Salbutamol Sulfate); Bromhexine (Bromhexine Hydrochloride); Guaifenesin (1 mg/5 mL; 2 mg/5 mL; 50 mg/5 mL), as syrup, according to its NAFDAC registration record.

Is Vifazer Syrup registered with NAFDAC?

Yes. Vifazer Syrup is listed on the NAFDAC register under registration number B4-5595, and its registration is active as of 1 November 2026.

Has Vifazer Syrup been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Vifazer Syrup in our automatically synced alert list.

How can I check that my pack of Vifazer Syrup is genuine?

Run a free authenticity scan with the NAFDAC number B4-5595, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Vifazer Syrup?

Follow your prescription or the leaflet in your pack. The official label says: The following dosages of albuterol tablets, USP are expressed in terms of albuterol base. Usual Dosage Pediatric Patients 6 to 12 Years of Age: For pediatric patients 6 to 12 years of age, the usual dosage is 2 mg three or four times a day. Adults and Pediatric Patients Over 12 Years of Age: For adults and pediatric patients over 12 years of age, the usual starting dosage is 2 …

What is Vifazer Syrup used for?

Albuterol tablets, USP are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease. (Summarised from the official U.S. FDA label for salbutamol (salbutamol sulfate) and bromhexine (bromhexine hydrochloride) and guaifenesin. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Vifazer Syrup? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.